Prostatitis is a group of diseases in which the prostate gland is affected by pathogens or/and certain non-infectious factors and the patient develops symptoms characterized by pain or discomfort in the pelvic region and abnormal urination. Acute prostatitis is an acute infectious disease localized in the prostate gland, with obvious symptoms of lower urinary tract infection and systemic symptoms such as chills, fever, myalgia, elevated white blood cell count and even pus cells in the urine and prostate fluid. Prostatitis should be treated in a comprehensive manner. Type I: Mainly broad-spectrum antibiotics, symptomatic treatment and supportive therapy. Those with urinary retention should apply suprapubic cystostomy to drain urine, and those with prostate abscesses can take surgical drainage. Type II: Treatment is based on antibiotics, choosing sensitive drugs, and treatment is maintained for at least 4-6 weeks, during which the patient should be evaluated for stage efficacy. If the efficacy is unsatisfactory, other sensitive antibiotics can be used instead. Alpha-blockers can be used to improve urinary symptoms and pain. Botanical preparations, NSAIDs and M-blockers can also improve the associated symptoms. Type IIIA: Oral antibiotics can be given for 2 to 4 weeks, and then the decision to continue antibiotic therapy is based on their efficacy feedback. Alpha-blockers are recommended to improve urinary symptoms and pain, and NSAIDs, botanicals and M-blockers are also available. Type IIIB: Treatment with alpha-blockers, NSAIDs, botanicals and M-blockers are available. Type IV: No treatment is generally required. The clinical progressiveness of chronic prostatitis is not clear enough to threaten the life and vital organ function of patients, and not all patients require treatment. The goal of treatment for chronic prostatitis is mainly to relieve pain, improve urinary symptoms and improve quality of life, and efficacy evaluation should be based on symptom improvement.